Aignostics Launches AI Software to Assess Tissue for Molecular Testing

Aignostics has launched HETA Clinical, a suite of AI tools that assesses digital pathology slides for tumor content and tissue quality to reduce molecular test failures and improve pathology workflow efficiency. The AI software helps verify sample adequacy before molecular testing, targeting a 10% to 20% failure rate caused by insufficient tumor tissue.

This Wire brief sits within Fusion42's coverage of AI Frontier Models, Diagnostics and Medtech.